Wang Hong Yan HY

Show results for

Unknown (46)
Proteomics (4)
Models (2)
Transcriptomics (1)
Genomics (1)
Metabolomics (1)

Organisms

Homo sapiens (5)
cellular organisms (2)
Mus musculus (1)

Repository

iProX (3)
BioModels (2)
biostudies-arrayexpress (1)
EGA (1)
MetaboLights (1)
pride (1)

Tissue

Cell culture (1)

Technology Type

Mass spectrometry (1)
Mass Spectrometry (1)
Proteogenomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2024 (4)
2025 (2)
2015 (1)
2023 (1)

UNIPROT ID/AC

O14543 (2)
O15524 (2)
O60674 (2)
P01112 (2)
P01579 (2)
P04049 (2)
P05231 (2)
P08887 (2)
P15260 (2)
P17676 (2)
P23458 (2)
P28482 (2)
P40189 (2)
P40763 (2)
P42224 (2)
P62136 (2)
P62993 (2)
P67775 (2)
Q02750 (2)
Q06124 (2)
Q07889 (2)

Metabolite Name

((4r)-4-((3r,5s,7r,9s,10s,12s,13r,14s,17r)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoyl)glycylglycine (1)
(+)-abscisic acid (1)
(+)-fluprostenol methyl ester (1)
(+-)5,6-DHET (1)
(-)-quebrachitol (1)
(-)-riboflavin (1)
(.+/-.)-2-methylarachidonoyl-2'-fluoroethylamide (1)
(.+/-.)-ethylphenidate (1)
(2-acetyloxy-3,6-diphenylcyclohexyl) acetate (1)
(2r)-3-hydroxyisovaleroylcarnitine (1)
(2r)-5-methoxy-2-methyl-2,3,8,9-tetrahydrofuro[2,3-h]chromen-4-one (1)
(2r,3r,4r,5r,6s)-2-[[(2r,3s,4s,5r,6r)-6-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-3,4,5-trihydroxyoxan-2-yl]methoxy]-6-methyloxane-3,4,5-triol (1)
(2r,3r,4r,6ar,6bs,8as,11r,12r,12as,14br)-2,3,12-trihydroxy-4,6a,6b,11,12,14b-hexamethyl-8a-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycarbonyl-1,2,3,4a,5,6,7,8,9,10,11,12a,14,14a-tetradecahydropicene-4-carboxylic acid (1)
(2r,3s,4s,5r,6r)-5-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-(hydroxymethyl)-6-(2-phenylethoxy)oxane-3,4-diol (1)
(2r,3s,4s,5r,6r)-6-[1,7-bis(4-hydroxyphenyl)heptan-3-yloxy]-5-[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy-2-[[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxymethyl]oxane-3,4-diol (1)
(3.beta.,5.alpha.)-4,4-dimethylcholesta-8,14,24-trien-3-ol (1)
(3r,5r,6r,7s,9s,10r,13r,17r)-17-((r)-5-methoxy-5-oxopentan-2-yl)-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthrene-3,6,7-triyl triacetate (1)
(3s,4s)-5-[(3s,4s)-4,10-dihydroxy-7,9-dimethoxy-3-methyl-3,4-dihydro-1h-benzo[g]isochromen-5-yl]-7,9-dimethoxy-3-methyl-3,4-dihydro-1h-benzo[g]isochromene-4,10-diol (1)
(3s,6r,9s,12r,15s,18r)-3-butan-2-yl-4,10,16-trimethyl-6,9,12,15,18-penta(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone (1)
(3z)-5-[(2,6-dichlorobenzyl)sulfonyl]-3-[(3,5-dimethyl-4-{[(2r)-2-(1-pyrrolidinylmethyl)-1-pyrrolidinyl]carbonyl}-1h-pyrrol-2-yl)methylene]-1,3-dihydro-2h-indol-2-one (1)
(4r)-4-((3r,5r,6s,7r,9s,10r,12s,13r,17r)-3,6,7,12-tetrahydroxy-10,13-dimethylhexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(4r)-4-((3r,5r,7r,9s,10s,12s,13r,14s,17r)-7,12-dihydroxy-10,13-dimethyl-3-(sulfooxy)hexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(4r)-4-((5s,7r,8r,9s,10s,12s,13r,17r)-7,12-dihydroxy-10,13-dimethyl-3-oxohexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(4r)-4-((5s,7r,9s,10s,13r,14s,17r)-7-hydroxy-10,13-dimethyl-3-oxohexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)
(5z,8z,11z,14z,17z-eicosapentaenoyl) coenzyme a (1)
(6s)-5-methyltetrahydrofolic acid (1)
(e)-1-(2,4-dihydroxyphenyl)-3-[4-(3-methylbut-2-enoxy)phenyl]prop-2-en-1-one (1)
(e)-3-(4-acetyloxy-2,3-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1h-naphthalen-1-yl)prop-2-enoic acid (1)
(e)-3-(4-methoxyphenyl)-1-[2,4,6-trimethoxy-3-(3-methylbut-2-enyl)phenyl]prop-2-en-1-one (1)
(r)-4-((5r,8r,9s,10s,13r,14s,17r)-10,13-dimethyl-3-oxohexadecahydro-1h-cyclopenta[a]phenanthren-17-yl)pentanoic acid (1)

IsPrivate

False (2)

Modelling Approach

Ordinary differential equation model (2)

Study type

Transcription profiling by array (1)

Release Date

2021 (11)
2025 (10)
2024 (5)
2022 (4)
2015 (3)
2023 (3)
2016 (3)
2019 (2)
2018 (2)
2017 (2)
2011 (1)
2009 (1)

Lab affiliation

sun yat-sen memorial hospital (1)

Previous page
1 / 6
You're on page 1
page 2
page 3
page 4
page 5
page 6
Next page

Sort by:

Relevance

Page size

Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients.

Not available

S-EPMC4402313 | biostudies-literature

Zinc excess increases cellular demand for iron and decreases tolerance to copper in Escherichia coli.

Not available

S-EPMC6851343 | biostudies-literature

Qi2013 - IL-6 and IFN crosstalk model

Qi2013 - IL-6 and IFN crosstalk model This model [BIOMD0000000544] describes the crosstalk between IFN-gamma and IL-6 induced signalling; it aims to outline mechanisms and factors that may control the interaction between both signalling pathways, discussing a role of heterodimer formation in signa...

2024-09-02 | BIOMD0000000544 | BioModels

Qi2013 - IL-6 and IFN crosstalk model (non-competitive)

Qi2013 - IL-6 and IFN crosstalk model (non-competitive) This model [BIOMD0000000543] describes the crosstalk between IFN-gamma and IL-6 induced signalling; it aims to outline mechanisms and factors that may control the interaction between both signalling pathways, discussing a role of heterodimer f...

2024-09-02 | BIOMD0000000543 | BioModels

An Interactive Web-Based Sexual Health Literacy Program for Safe Sex Practice for Female Chinese University Students: Multicenter Randomized Controlled Trial.

Not available

S-EPMC7998327 | biostudies-literature

The gut microbiota-butyrate axis restores cardiomyocyte autophagy to alleviate Doxorubicin-induced cardiotoxicity

Abstract

Background Doxorubicin (DOX), an anthracycline chemotherapeutic agent, is widely used for treating various malignancies. However, its clinical application is limited by dose-dependent cardiotoxicity (DOX-induced cardiotoxicity, DIC). Recent studies have shown that the gut microbiot...

2025-09-16 | MTBLS12997 | MetaboLights

HaCaT ACSL4mRNA probe pull-down MS

ACSL4mRNA probe was designed for pull-down experiments in HaCaT lysates

ORGANISM(S): Homo sapiens (Human)

2025-10-13 | PXD052755 | Pride

Hacat acsl4mrna pull-down ms